Trial intelligence / Profile preview

Transtympanic Steroids vs Gentamicin in Unilateral Ménière's Disease

NCT00802529Phase 3Completed

Sponsor
Imperial College London
Start
Apr 2009
Primary completion
May 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone in Ménière's disease, sponsored by Imperial College London. Started Apr 2009; status: completed.

02

Drugs

methylprednisolone
03

Conditions

Ménière's disease

Beyond the preview

Go deeper on NCT00802529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00802529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call